Frailty status and increased risk for falls: The role of anticholinergic burden
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 90, 104136
Abstract
No abstract availableKeywords
Funding Information
- department of the Scientific Research Projects of University of Health Sciences, Turkiye
This publication has 55 references indexed in Scilit:
- Impact of drug burden index on adverse health outcomes in Irish community-dwelling older people: a cohort studyBMC Geriatrics, 2019
- Falls in institutionalized elderly with and without cognitive decline A study of some factorsDementia & Neuropsychologia, 2019
- DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilitiesInternational Journal of Clinical Pharmacy, 2019
- Comparing clinician descriptions of frailty and geriatric syndromes using electronic health records: a retrospective cohort studyBMC Geriatrics, 2017
- The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the ‘Oldest Old’: A Systematic Review of the LiteratureDrugs & Aging, 2015
- Use of anticholinergics and the risk of cognitive impairment in an African American populationNeurology, 2010
- Anticholinergic Activity of 107 Medications Commonly Used by Older AdultsJournal of the American Geriatrics Society, 2008
- Impact of Anticholinergics on the Aging Brain: A Review and Practical ApplicationAging Health, 2008
- Pharmacodynamics in Older Adults: A ReviewThe American Journal of Geriatric Pharmacotherapy, 2007
- Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort studyBMJ, 2006